Provides a comprehensive overview of the pharmacological management of systolic and diastolic heart failure based on established evidence.
No takes yet. Share an insight, caveat, or question.
Supports established HF pharmacotherapy; leaves open optimization of digoxin and CCBs in contemporary regimens.
Wilbert S. Aronow (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: